Haisco Pharmaceutical signs licensing agreement with AbbVie Group

AI Briefing

• – Haisco Pharmaceutical and AbbVie Group announce licensing agreement for undisclosed terms.
• – Details of the agreement are not yet publicly available.
• – Terms of the partnership are expected to drive growth for both companies.